TECNOTREE
19.9.2022 11:01:39 CEST | Business Wire | Press release
Tecnotree, a leading global Digital Transformation Partner for the Telecom Industry, is the first non-telco to be certified for real-world open API implementation on the leader board for TM Forum Open API Conformance. The certifications were carried out jointly with MTN in live operations within the MTN environment and demonstrated the successful implementation of Open APIs in commercial products and real-world deployments. Alignment to industry standards and best practices have been a part of Tecnotree’s DNA and its Digital Transformation strategy and proves Tecnotree’s commitment to industry standards, customers, and partner ecosystems. This landmark achievement makes Tecnotree the first Digital Platform Company among a list of CSPs like Verizon, Bell, and JIO, for certified real-world open API implementation.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220919005054/en/
Tecnotree is the First Digital Platform Company in the World to be Certified for Real-World Open API Implementation by TM Forum (Photo: Business Wire)
Tecnotree’s Digital Platform powered with Open APIs using Open Digital Architecture enables quick and flexible integration to transform telecom business and operation models that extends beyond connectivity to monetise platform-based business models and partner ecosystems across verticals.
“We congratulate Tecnotree for being the first non-telco to achieve real-world certification for Open APIs deployed in live operation with MTN,” commented George Glass, CTO of TM Forum. “This is a path-breaking move by a software solutions provider and reaffirms Tecnotree’s commitment to open standards and their investment in next-generation product modernization. Tecnotree has been a great supporter of TM Forum’s work and is demonstrating the business value of Open APIs in enabling digital transformation for their customers.”
Monzer Ali, CTIO of MTN Uganda commented, “MTN and Tecnotree have been at the forefront of aligning with TM Forum frameworks (TAM, SID, Open APIs, eTOM) in our digital transformation journey. Tecnotree Digital BSS Suite is TMF ODA’s component-based architecture and is fully cloud-enabled, having an orchestration of micro-services capability that allows us to provide not only connectivity services for our subscribers but also digital services from adjacent industries, thus truly helping us monetize the power of 5G.”
Padma Ravichander, CEO of Tecnotree Corporation said, “This recognition is a true testimony of our journey as a pioneer in TM Forum’s Open API certification. Real-world Open API conformance and certification for Tecnotree is our commitment towards our customers to help them unlock and monetize the power of 5G with a range of digital products and services. These solutions can be provided to their customers, with seamless connectivity, speed, agility, and interoperability, on our Tecnotree Digital BSS platform. Our platform further enables operators to partner with the industry’s best ecosystem players to monetize B2B and B2B2X non-telco offerings by leveraging 5G for new digital multi-experiences.”
TM Forum Open API suite was developed in collaboration to drive IT agility, and digital business transformation. The certification recognizes how well your industry solutions, business processes, or open APIs align within the industry standards. They unlock a range of growth opportunities by providing exposure to new products and services while reducing cost and time to market. A large number of major global operators and vendors use the TM Forum Open API conformance, and the APIs are deployed all over the world.
About Tecnotree
Tecnotree is a 5G-ready digital Business Support System (BSS) player, with AI/ML capabilities and multi-cloud extensibility. Tecnotree is the first company in the world to be Platinum Certified by TM Forum Open API standards, and our agile and open-source Digital BSS Stack comprises the full range (order-to-cash) of business processes and subscription management for telecom and other digital services industries creating opportunities beyond connectivity. Tecnotree also provides Fintech and B2B2X multi-experience digital marketplace to its subscriber base through the Tecnotree Moments platform to empower digitally connected communities across gaming, health, education, OTT, and other vertical ecosystems. Tecnotree digital platform products and services today serve over 1 Billion Subscribers globally in over 70 countries. Tecnotree is listed on Helsinki Nasdaq (TEM1V).
For more information, please visit www.tecnotree.com
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220919005054/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Murata Launches Ultra-Low Power AMR Sensors to Boost Battery Life in Healthcare and Wearables Devices27.4.2026 04:00:00 CEST | Press release
Murata Manufacturing Co., Ltd. (TOKYO: 6981) (ISIN: JP3914400001) has commenced mass production of its MRMS166R and MRMS168R anisotropic magnetoresistance (AMR) sensors for healthcare, wearable, and IoT devices. The MRMS166R is the first AMR sensor to combine an average current consumption of 20 nA with operation from a 1.2 V supply, enabling extended battery life in coin cell-powered systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260413296947/en/ [Murata Manufacturing Co., Ltd.] AMR sensor The devices are solid-state magnetic sensors used for switching applications. They detect the presence or absence of a magnetic field and generate an output signal that system logic uses to control functions such as transitions between active and sleep modes. This enables contactless switching without mechanical components, improving reliability, and supporting sealed, miniaturized designs. Automatic switching between active and
Sun Pharma signs Definitive Agreement to Acquire Organon27.4.2026 01:51:00 CEST | Press release
Organon stockholders to receive US$ 14.00 per share in cashThe deal values Organon at EV of US$ 11.75 billionCombined Business leverages complementary portfolios and global scale for sustained long‑term value creation Sun Pharmaceutical Industries Limited(Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (together with its subsidiaries and/or associated companies, “Sun Pharma”) and Organon & Co. (NYSE: OGN) (“Organon”) today announced that they have entered into a definitive agreement under which Sun Pharma will acquire all outstanding shares of Organon for US$ 14.00 per share in an all‑cash transaction with an enterprise valuation of US$ 11.75 billion. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260426881370/en/ Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, in 2021. Organon has a legacy of deep trust and strong brand equit
Andersen Global udvider sin tilstedeværelse i Afrika med lanceringen af medlemsfirma i Cameroun26.4.2026 20:56:00 CEST | Pressemeddelelse
Andersen Global træder ind på det camerounske marked, idet Phoenix Advisory bliver medlemsfirma og overgår til Andersen-brandet. Andersen in Cameroun er et specialiseret rådgivningsfirma, der leverer strategiske, erhvervsmæssige, finansielle og operationelle rådgivningsydelser til organisationer i forskellige vækstfaser. Firmaet er grundlagt af fagfolk med erfaring fra store internationale organisationer og kombinerer et stærkt lokalt og centralafrikansk funderet kendskab til forretningsmæssige, juridiske og skattemæssige regler med en skræddersyet tilgang, der har til formål at skabe konkrete og målbare resultater for klienterne. "Overgangen til Andersen-brandet afspejler vores engagement i at vokse sammen med vores kunder og imødekomme stadig mere komplekse behov," udtalte administrerende partner Albert Désiré Zang. "Vi tror på, at langsigtet succes skabes gennem tillid, kvalitet og vedvarende support. At blive et medlemsfirma styrker vores evne til at levere gennemtænkte, bæredygtig
PMCOrganometallix Announces Price Increase on All Products24.4.2026 22:55:00 CEST | Press release
Due to significant changes in market conditions, PMC Organometallix, Inc. announces that effective May 1, 2026, or as contracts permit, prices across all product lines globally will increase by 10-25%. This adjustment is driven by sustained cost pressures from key inputs including rising raw material costs and escalating freight and logistics expenses. While the company has been absorbing these increases, the current economic environment brought on by the geopolitical crisis of the Iran conflict requires this adjustment to continue providing the high-quality, consistent materials and supply reliability that customers expect. PMC Organometallix will implement these changes in a transparent, collaborative manner and values your partnership while navigating these economic challenges. Customers with questions or to discuss a specific situation should contact their account representative. About PMC Group PMC Group is a growth-oriented, diversified, global chemicals and plastics company deli
Frankfurt Higher Regional Court upholds BESREMi® arbitral award in favor of AOP Health24.4.2026 18:52:00 CEST | Press release
Today, the Higher Regional Court of Frankfurt upheld the February 20251 partial final ICC arbitral award in favor of AOP Orphan Pharmaceuticals GmbH (“AOP Health”) in its dispute with PharmaEssentia Corp. (“PharmaEssentia”). The ruling confirms the award which found the Taiwanese company to be liable for certain damages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260424005227/en/ Portrait Dr. Rudolf Widmann, Founder AOP Health Credit: AOP Health/Daniel Ospelt Dr. Rudolf Widmann, one of the two founders of AOP Health, explains: “We very much welcome the Frankfurt Higher Regional Court’s decision that confirms our position. In the interest of our patients, we are dedicated to maintaining stable and sustainable access to BESREMi® and to responsibly navigating future challenges.” The Product in Dispute The conflict centers around BESREMi® (ropeginterferon alfa-2b), a product launched in 2019 and developed by AOP Health into
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom